Search

An expert group set up by the Commission has set out guidelines on giving European industry a competitive edge in deploying Key Enabling Technologies (KETs)

Stephan Tanda, a director of DSM, the Dutch life sciences company, has been appointed to head the pan-European industry body

Karolinska Institutet is making major efforts to enhance its technology transfer and commercialisation system, and is currently working on a long-term strategy for innovation and research

Máire Geoghegan-Quinn, Research, Innovation and Science Commissioner has announced the winner of the competition to name the future EU funding programme for research and innovation

On May 24 the European Commission made a commitment to create a single market for intellectual property rights. In a series of articles we will be looking into the details of this latest initiative, reporting on progress, and assessing outcomes

Biofuels could grow to 9% of global transport fuels by 2030 but getting there will take more research and clear-sighted government policy

The pharmaceutical sector launched a Framework for Action to tackle non-communicable diseases including cardiovascular disease, cancer, diabetes and chronic respiratory diseases that are posing a threat to public health, and public and private finances worldwide.

With around 400,000 students, five of the UK’s top 10 research institutions, and more than 20 Nobel prize winners, London has as much claim to be the centre of the country’s science as Oxford or Cambridge. So why does it have such a hard job holding on to its spin-out companies, particularly in life sciences?